Cartesian Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2k | 708 | 10.22 |
| 2025-06-30 | $7.4k | 708 | 10.39 |
| 2025-03-31 | $9.3k | 708 | 13.18 |
| 2024-12-31 | $13k | 708 | 17.91 |
| 2024-09-30 | $11k | 708 | 16.12 |
| 2024-06-30 | $19k | 708 | 27.01 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors